# Transmutex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/transmutex

- Industry: Renewable Energy
- Headquarters: Geneva, Switzerland
- Website: www.transmutex.com/
- Total disclosed funding: $29M
- Latest round: Series A (Jan 29, 2024)
- Investors on record: 9

## About

Based in Geneva, Switzerland, and founded in 2019 by CEO Franklin Servan-Schreiber, Transmutex SA operates as a provider of advanced nuclear engineering solutions, focusing on transforming nuclear waste into clean energy and producing medical isotopes for diagnostic and therapeutic applications. In January 2025, Transmutex SA raised CHF 4.3 million of grant funding from new investor U.S. Department of Energy. The company provides a wide range of nuclear engineering solutions, such as advanced accelerator technologies for energy production, various methods to reduce nuclear waste volume and radiotoxicity, and the development of radionuclides for medical applications. The company will use the February 2025 funding to advance its initiative aimed at reducing nuclear waste volume and half-life.

## Funding rounds

- Series A, Jan 29, 2024, $23M — Union Square Ventures, HCVC, Presight Capital, AlleyCorp, At One Ventures, Verve Ventures, FONGIT, House Of Ventures, Steel Atlas
- Series A, Jul 30, 2021, $5.8M — Union Square Ventures, AlleyCorp

## Investors

- Union Square Ventures (https://capitalatlas.ai/funds/union-square-ventures) — Series A
- AlleyCorp — Series A
- HCVC (https://capitalatlas.ai/funds/hcvc) — Series A
- Presight Capital — Series A
- At One Ventures (https://capitalatlas.ai/funds/at-one-ventures) — Series A
- Verve Ventures (https://capitalatlas.ai/funds/verve-ventures) — Series A
- FONGIT (https://capitalatlas.ai/funds/fongit) — Series A
- House Of Ventures (https://capitalatlas.ai/funds/house-of-ventures) — Series A
- Steel Atlas (https://capitalatlas.ai/funds/steel-atlas) — Series A